These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 38127816)
1. Autophagic dysfunction and gut microbiota dysbiosis cause chronic immune activation in a Drosophila model of Gaucher disease. Atilano ML; Hull A; Romila CA; Adams ML; Wildfire J; Ureña E; Dyson M; Ivan-Castillo-Quan J; Partridge L; Kinghorn KJ PLoS Genet; 2023 Dec; 19(12):e1011063. PubMed ID: 38127816 [TBL] [Abstract][Full Text] [Related]
2. A Drosophila Model of Neuronopathic Gaucher Disease Demonstrates Lysosomal-Autophagic Defects and Altered mTOR Signalling and Is Functionally Rescued by Rapamycin. Kinghorn KJ; Grönke S; Castillo-Quan JI; Woodling NS; Li L; Sirka E; Gegg M; Mills K; Hardy J; Bjedov I; Partridge L J Neurosci; 2016 Nov; 36(46):11654-11670. PubMed ID: 27852774 [TBL] [Abstract][Full Text] [Related]
3. Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery. Hull A; Atilano ML; Gergi L; Kinghorn KJ Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220381. PubMed ID: 38368939 [TBL] [Abstract][Full Text] [Related]
4. The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease. Kinghorn KJ; Asghari AM; Castillo-Quan JI Neural Regen Res; 2017 Mar; 12(3):380-384. PubMed ID: 28469644 [TBL] [Abstract][Full Text] [Related]
5. The relationship between glucocerebrosidase mutations and Parkinson disease. Migdalska-Richards A; Schapira AH J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):77-90. PubMed ID: 26860875 [TBL] [Abstract][Full Text] [Related]
6. Death by over-eating: The Gaucher disease associated gene GBA1, identified in a screen for mediators of autophagic cell death, is necessary for developmental cell death in Drosophila midgut. Dasari SK; Schejter E; Bialik S; Shkedy A; Levin-Salomon V; Levin-Zaidman S; Kimchi A Cell Cycle; 2017; 16(21):2003-2010. PubMed ID: 28933588 [TBL] [Abstract][Full Text] [Related]
7. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease. Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179 [TBL] [Abstract][Full Text] [Related]
8. PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, Zhao X; Lin Y; Liou B; Fu W; Jian J; Fannie V; Zhang W; Setchell KDR; Grabowski GA; Sun Y; Liu CJ Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2210442120. PubMed ID: 36574647 [TBL] [Abstract][Full Text] [Related]
9. Glitazone Treatment Rescues Phenotypic Deficits in a Fly Model of Gaucher/Parkinson's Disease. Shola-Dare O; Bailess S; Flores CC; Vanderheyden WM; Gerstner JR Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884544 [TBL] [Abstract][Full Text] [Related]
11. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration. Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872 [TBL] [Abstract][Full Text] [Related]
12. Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease. Kumar M; Srikanth MP; Deleidi M; Hallett PJ; Isacson O; Feldman RA Hum Mol Genet; 2023 May; 32(11):1888-1900. PubMed ID: 36752535 [TBL] [Abstract][Full Text] [Related]
13. Functional and genetic characterization of the non-lysosomal glucosylceramidase 2 as a modifier for Gaucher disease. Yildiz Y; Hoffmann P; Vom Dahl S; Breiden B; Sandhoff R; Niederau C; Horwitz M; Karlsson S; Filocamo M; Elstein D; Beck M; Sandhoff K; Mengel E; Gonzalez MC; Nöthen MM; Sidransky E; Zimran A; Mattheisen M Orphanet J Rare Dis; 2013 Sep; 8():151. PubMed ID: 24070122 [TBL] [Abstract][Full Text] [Related]
14. Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death. Keatinge M; Bui H; Menke A; Chen YC; Sokol AM; Bai Q; Ellett F; Da Costa M; Burke D; Gegg M; Trollope L; Payne T; McTighe A; Mortiboys H; de Jager S; Nuthall H; Kuo MS; Fleming A; Schapira AH; Renshaw SA; Highley JR; Chacinska A; Panula P; Burton EA; O'Neill MJ; Bandmann O Hum Mol Genet; 2015 Dec; 24(23):6640-52. PubMed ID: 26376862 [TBL] [Abstract][Full Text] [Related]
15. GBA1 and The Immune System: A Potential Role in Parkinson's Disease? Al-Azzawi ZAM; Arfaie S; Gan-Or Z J Parkinsons Dis; 2022; 12(s1):S53-S64. PubMed ID: 36057834 [TBL] [Abstract][Full Text] [Related]
16. Mitochondria and quality control defects in a mouse model of Gaucher disease--links to Parkinson's disease. Osellame LD; Rahim AA; Hargreaves IP; Gegg ME; Richard-Londt A; Brandner S; Waddington SN; Schapira AHV; Duchen MR Cell Metab; 2013 Jun; 17(6):941-953. PubMed ID: 23707074 [TBL] [Abstract][Full Text] [Related]